Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4

Quest Diagnostics Inc.

DGXNYSEEQUITYCurrent

Changes in Beneficial Ownership

Filed Aug 31, 2026Accepted Aug 31, 2026, 4:37 PM EDTFiling CIK 1022079Accession 0001022079-26-000089
Share

Structured filing — 4

wk-form4_1788208632.xml

Open full document ↗

Filing details

Report period
2026-08-28
Issuer
QUEST DIAGNOSTICS INC
Issuer CIK
0001022079
Trading symbol
DGX
Rule 10b5-1 indication
Checked

Reporting owner 1

Name
PREVOZNIK MICHAEL E
Reporting owner CIK
0001222679
Relationship
Officer
Officer title
SVP & General Counsel
Address
500 PLAZA DRIVE, SECAUCUS, NJ, 07094

Non-derivative transactions

Non-derivative transactions · 5 reported rows
SecurityTransaction dateCodeAmountA / DPrice (USD)Owned afterOwnershipTimeliness
Common Stock2026-08-28M · Form 4[F1]22,677A112.1760,234D
Common Stock2026-08-28S · Form 4[F1]16,010D242.8755[F2]44,224D
Common Stock2026-08-28S · Form 4[F1]6,237D243.6275[F3]37,987D
Common Stock2026-08-28S · Form 4[F1]430D244.5148[F4]37,557D
Common Stock2026-08-28G · Form 5[F5]1,000D036,557DE
Table key
M · Form 4
Exempt derivative exercise or conversion under Rule 16b-3
A
Acquired
D
Direct
S · Form 4
Sale on the market or privately
G · Form 5
Bona fide gift

Non-derivative holdings

Non-derivative holdings · 1 reported row
SecurityAmount ownedOwnershipNature of ownership
Common Stock5,780[F6]I401(k)/SDCP
Table key
I
Indirect

Derivative transactions

Derivative transactions · 1 reported row
SecurityConversion / exercise price (USD)Transaction dateCodeAmountA / DPrice (USD)ExercisableExpiresUnderlying securityUnderlying sharesOwned afterOwnership
Non-Qualifed Stock Option (right to buy)112.172026-08-28M · Form 4[F1]22,677D112.17[F7]2030-02-18Common Stock22,6770D
Table key
M · Form 4
Exempt derivative exercise or conversion under Rule 16b-3
D
Direct

Footnotes

F1
This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.↩ 1↩ 2↩ 3↩ 4↩ 5
F2
This transaction was executed in multiple trades at prices ranging from $242.270 to $243.269. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.↩ 1
F3
This transaction was executed in multiple trades at prices ranging from $243.270 to $244.225. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.↩ 1
F4
This transaction was executed in multiple trades at prices ranging from $244.280 to $245.247. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.↩ 1
F5
On August 28, 2026, the reporting person made a charitable gift of 1,000 shares, a transaction eligible for deferred reporting on Form 5. The reporting person has chosen to report such transaction early on this Form 4.↩ 1
F6
These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.↩ 1
F7
The options vested in three equal annual installments beginning on the first annual anniversary of the grant date.↩ 1

Signature 1

Signed
Sean D. Mersten, Attorney in Fact for Michael E. Prevoznik
Date
2026-08-31

Company context

Quest Diagnostics works across healthcare to create a healthier world, one life at a time. We help connect people, from clinicians to consumers, with laboratory insights that illuminate a path to better health. With a focus on delivering smarter, simpler testing, our insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics serves half the physicians and hospitals in the United States and one in three adult Americans each year, and our nearly 60,000 employees work together to deliver diagnostic insights that inspire actions to transform lives. www. QuestDiagnostics.com.

Current securities

Recent company filings

  1. SCHEDULE 13G - filed by STATE STREET CORP regarding QUEST DIAGNOSTICS INCNov 10, 2026
  2. 10-Q filingOct 23, 2026
  3. Other EventsOct 22, 2026
  4. Results of Operations and Financial ConditionOct 22, 2026
  5. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsOct 6, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.